• Facing
    Metastatic Cancer
    • Is Metastatic Cancer Curable?
    • Access to the Right Treatment
    • Registering with Cancer Commons
    • Enroll in XCELSIOR
    • Can a Virtual Tumor Board Help?
    • Get Help With Your Treatment Plan
  • New Cancer Research
    & Perspectives
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • Our Story
    • It Started in 1998…
    • We’re Here to Help
    • Why We Go to Work Each Day
    • Our Services
    • Meet the Team
    • Why we built a “Commons”
    • Our Partners
    • Keeping Our Services Free
    • Talk to Us
  • Support Our
    Free Services
    • Donate Now
    • Many Ways to Give
    • Funding Initiatives
    • What Your Support Makes Possible
  • Facing
    Metastatic Cancer
    • Is Metastatic Cancer Curable?
    • Access to the Right Treatment
    • Registering with Cancer Commons
    • Enroll in XCELSIOR
    • Can a Virtual Tumor Board Help?
    • Get Help With Your Treatment Plan
  • New Cancer Research
    & Perspectives
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • Our Story
    • It Started in 1998…
    • We’re Here to Help
    • Why We Go to Work Each Day
    • Our Services
    • Meet the Team
    • Why we built a “Commons”
    • Our Partners
    • Keeping Our Services Free
    • Talk to Us
  • Support Our
    Free Services
    • Donate Now
    • Many Ways to Give
    • Funding Initiatives
    • What Your Support Makes Possible
  • Donate
 

The Big Picture

Learn more about what’s new in advanced cancer research and treatment, including screening and statistics, using artificial intelligence to improve treatment, and other new horizons in cancer care.

  • November 10, 2020 

    How to Learn About Cancer in a Classroom: Shaping Compassionate Doctors

    With: Marin Langlieb

    The patients and caregivers we serve here at Cancer Commons rely on their doctors to provide expert, compassionate care. Building the skills to give such care can begin early in a doctor’s education. Here, for a change of pace, our… Read more »

  • September 9, 2020 

    Is Cancer the Best Way to Die?

    With: Richard Smith, CBE, FMedSci

    In 2014, the prestigious medical research journal The BMJ published a controversial piece called “Dying of cancer is the best death.” Here, our Curious Dr. George asks the author of that piece, Richard Smith, CBE, FMedSci, if and how his thoughts… Read more »

  • August 21, 2020 

    The Power of Precision Medicine is Exemplified by Tempus

    With: Nike Beaubier, MDNamratha Sastry, PhD

    Tempus—a tech company & partner of Cancer Commons—empowers doctors to make data-driven decisions for their patients in real time. Learn how.

  • August 15, 2020 

    A Case of Male Breast Cancer Patient with CHEK2*1100delC MutationBookmark

    George Lundberg, MD

    Research paper from Cureus curated by Editor in Chief George Lundberg, MD, who notes: 

    Breast cancer in men is unusual but important. This academic paper outlines the case of a specific patient who was found to have a genetic mutation that could explain why he was diagnosed at a relatively younger age.

    Go to full paper published in Cureus.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • August 14, 2020 

    Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic DiseaseBookmark

    George Lundberg, MD

    Research paper from Cancers curated by Editor in Chief George Lundberg, MD, who notes: 

    Instead of focusing on “curing” cancer, the authors of this academic research paper focus on approaches to managing cancer as a chronic disease.

    Go to full paper published in Cancers.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • June 29, 2020 

    Cancer Screening Programs Influence Incidence and Causes of Cancer DeathsBookmark

    Lola Rahib, PhD

    Article from ASCO Daily News curated by Director of Scientific and Clinical Affairs, Lola Rahib, PhD.

    In collaboration with MD Anderson Cancer Center and the Pancreatic Cancer Action Network, Cancer Commons presented new research at the American Society of Clinical Oncology (ASCO)’s virtual 2020 meeting. The findings show that, by 2040, we will likely see notable changes in which cancer types are most common and which are most deadly, highlighting the influence of cancer screening programs. This research was led by Dr. Rahib at Cancer Commons.

    Go to full article published by ASCO Daily News.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • May 30, 2020 

    What Have I Learned in More Than Half a Century in Cancer Medicine?Bookmark

    George Lundberg, MD

    Article from The ASCO Post curated by Editor in Chief George Lundberg, MD, who notes: 

    “Patients with cancer need to be embraced with love and compassion. They need caring beyond medicine.”

    Go to full article published by The ASCO Post.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • April 27, 2020 

    The Challenges of Using Artificial Intelligence to Improve Cancer Treatment

    With: Razelle Kurzrock, MDJeff Shrager, PhD

    In a previous post, CureMatch co-founder Razelle Kurzrock, MD, told us all about her company’s artificial intelligence (AI) platform that matches patients with treatments based on their cancer’s molecular profile. Here, AI expert Jeff Shrager, PhD, responds, and Kurzrock offers… Read more »

  • March 2, 2020 

    Using Artificial Intelligence to Match Combination Targeted Therapies in Oncology

    With: Razelle Kurzrock, MD

    A Q&A with Razelle Kurzrock, MD, Director of the Center for Personalized Cancer Therapy and the Rare Tumor Clinic at U.C. San Diego, and Co-Founder and Board Member of CureMatch, Inc. Email: razelle@curematch.com Q: The new understanding of many cancers… Read more »

  • February 22, 2020 

    ‘Fail First’ No More: Pennsylvania Moves to Expand Coverage of Treatments for Advanced CancersBookmark

    George Lundberg, MD

    Article from The Philadelphia Inquirer curated by Editor in Chief George Lundberg, MD, who notes: 

    A new Pennsylvania law requires insurance coverage for use of FDA-approved best drugs first, rather than only after failing with a cheaper alternative.

    Go to full article published by The Philadelphia Inquirer.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • »

Cancer Commons’ scientists and doctors were very helpful in identifying possible clinical trials for our son’s rare brain tumor.

Joan
Mother of brain tumor patient


You can makea differenceDonate

Precision oncology is very complicated and changes every day. The scientists of Cancer Commons provide rapid, compassionate, scientifically sound information about best options, a remarkable free service.

Razelle Kurzrock, MD
U.C. San Diego, CureMatch, Inc.

Cancer Commons is a nonprofit that provides hope to advanced cancer patients by helping them identify and access their best possible treatment. We offer a highly customized experience, connecting patients with our collaborative network of nurse navigators, PhD scientists, and national experts. We learn from every patient we serve, so we can help many more.

Get free advice on cancer treatment options

Patient Services

  • Get Access to the Right Treatment
  • Request an Options Report
  • Frequently Asked Questions (FAQ)

Perspectives

  • Latest Research & Perspectives
  • Treatment Options
  • Navigating Treatment
  • Living with Cancer
  • Patient Stories
  • Curious Dr. George
  • The Big Picture
  • COVID-19 and Cancer
  • Peer-Reviewed Publications

Organization

  • Our Story
  • The Team
  • Board of Directors
  • Advisory Board
  • The Commons
  • Partners
  • Expert Physician Advisors
  • Open Positions

Corporate & Regulatory

  • News and Events
  • Funding Initiatives
  • Contact Us
  • Cancer Commons International
  • Audited Financials

Support & Giving

  • Donate
  • Other Ways to Give
  • Funding Initiatives
  • What Your Support Makes Possible


Donate

Cancer Commons
650 Castro Street, Suite 120-522
Mountain View, CA 94041, USA
650-289-4044

Patients Hotline

877-971-1200

If you have advanced or metastatic cancer, and you are a U.S. resident, our experts are here to help you identify the best-possible treatment options—all at no cost to you. Our one-on-one support is driven by the latest, evidence-based scientific discoveries.

To get started, simply fill out this form. You will then receive an email with a link to submit additional information.

The sooner we receive all of your information, the sooner we can help.

  • Privacy Policy

© 2021 Cancer Commons.